Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1701-1711

  El Khatib, Firas H ^a   Russell, Steven J ^b   Magyar, Kendra L ^b   Sinha, Manasi ^b   McKeon, Katherine ^a   Nathan, David M ^b   Damiano, Edward R ^a  

^a Boston University   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BIHORMONAL BIONIC ENDOCRINE PANCREAS; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL DEVICE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TIME TO MAXIMUM PLASMA CONCENTRATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL; TREATMENT OUTCOME;

EID: 84898436863     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4151     Document Type: Article

References (47)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on th e development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of D iabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563-25694.
3. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643-2653.
4. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997;46:271-286.
5. Leese GP, Wang J, Broomhall J. Frequency of severe hypoglycemia requiring emergency treatment i n type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26:1176-1180.
6. Cengiz E, Xing D, Wong JC, et al. T1D Exchange Clinic Network. Severe h ypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013;14:447-454.
7. Weinstock RS, Xing D, Maahs DM, et al. T1D Exchange C linic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013;98:3411-3419.
8. Petitti DB, Klingens mith J, Bell RA, et al. SEARCH for Diabetes in Youth Study Group. Glycemic control in youth with diabetes: The SEARCH for diabetes in Youth Study. J Pediatr. 2009;155:668-72.e3.
9. Tamborlane RW, Bergen stal RM, Miller KM, DuBose SN, Hall CA T1D Exchange Clinic Network. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2012;97:4383-4389.
10. Wood JR, Miller KM, Maahs DM, et al. T1D Exchange Clinic Network. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36:2035-2037.
11. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902-1912.
12. Amiel SA Sherwin RS Simonson DC Lauritano AA Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes N Engl J Med. 1986 315: 215-219.
13. Kerouz N, el-Hayek R, Langhough R, MacDonald MJ. Insulin doses in children using conventional therapy for insulin dependent diabetes. Diabetes Res Clin Pract. 1995;29:113-120.
14. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Trans Med. 2010;2:27ra27.
15. Russell SJ, El-Kha tib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care. 2012;35:2148-2155.
16. Elleri D, A llen JM, Kumareswaran K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care. 2013;36:838-844.
17. Dassau E, Zis ser H, Harvey RA, et al. Clinical evaluation of a personalized artificial pancreas. Diabetes Care. 2013;36:801-809.
18. Haidar H, Legault L, Dallaire M, et al. Glucose-responsive in sulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Can Med Assoc J. 2013;185:297-305.
19. Phillip M, Battelino T, Atla s E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368: 824-833.
20. O'Grady MJ, Retterath AJ, Keenan DB, et al. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care. 2012;35:2182-2187.
21. Ruiz JL, Sherr JL, Cengiz E, et al. Effect of insulin feedback on closed-loop glucose control: a crossover study. J Diabetes Sci Technol. 2012;6:1123-1130.
22. Van Bon AC, Jonker LD, Koebrugge R, Koops R, Hoekstra JB, DeVries JH. Feasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursions. J Diabetes Sci Technol. 2012;6:1114-1 122.
23. Weinzimer SA, Sherr JL, Cengiz E, et al. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care. 2012; 35:1994-1999.
24. Elleri D, Allen JM, Biagioni M, et al. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pe diatr Diabetes. 2012; 13:449-453.
25. Nimri R, Atlas E, Ajzensztejn M, Miller S, Oron T, Phillip M. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: The DREAM P roject. Diabetes Technol Ther. 2012;14:728-735.
26. Breton M, Farret A, Bruttomesso D, et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintai ns near normoglycemia. Diabetes. 2012;61:2230-2237.
27. Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women wit h type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34:2527-2529.
28. Steil GM, Palerm CC, Kurtz N, et al. The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab. 2011;96: 1402-1408.
29. Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomized controlled studies. BMJ. 2011;342:d1855.
30. Elleri D, Allen JM, Nodale M, et al. Automated overnight closedloop glucose control in young children with type 1 diabetes. Diabetes Technol Ther. 2011;13:419-424.
31. El Youssef J, Castle JR, Branigan DL, et al. A controlled study of the effectiveness of an adaptive closed-loop algorithm to minimize corticosteroid-induced stress hype rglycemia in type 1 diabetes. J Diabetes Sci Technol. 2011;5:1312-1326.
32. van Bon AC, Hermanides J, Koops R, Hoekstra JB, DeVries JH. Postprandial glycemic excursions with the use of a clo sed-loop platform in subjects with type 1 diabetes: a pilot study. J Diabetes Sci Technol. 2010;4:923-928.
33. Castle JR Engle JM El Youssef J et al. Novel use of glucagon in a closed-loop sy stem for prevention of hypoglycemia in type 1 diabetes Diabetes Care. 2010 33 1282-1287.
34. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care. 2010;33:1072-1076.
35. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 dia betes: a phase 2 randomised crossover trial. Lancet. 2010;375:743-751.
36. Renard E, Place J, Cantwell M, Chevassus H, Palerm CC. Closedloop insulin delivery using a subcutaneous glucose sen sor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care. 2010;33:121-127.
37. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: The Virginia experience. J Diabetes Sci Technol. 2009;3:1031-1038.
38. Bruttomesso D, Farret A, Costa S, et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol. 2009;3:1014-1021.
39. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31:934-939.
40. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55:3344-3350.
41. Garg SK, Voelmle MM, Gottlieb PA. Time lag characterization of two continuous glucose monitoring systems. Diabetes Res Clin Pract. 2010;87:348-353.
42. Davey RJ, Low C, Jones TW, Fournier PA. Contribution of an intrinsic lag of continuous glucose monitoring systems to differences in measured and actual glucose concentrations changing at variable rates in vitro. J Diab etes Sci Technol. 2010;4:1393-1399.
43. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini J. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose mo nitoring (CGM): is CGM ready for real time Diabetes Technol Ther. 2009;11:11-18.
44. American Diabetes Association. Standard of medical care in diabetes. Diabetes Care. 2013;36(suppl 1):S11-S66.
45. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31:1473-1478.
46. Damiano ER, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care. 2013;36:251-259.
47. Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes. 2013;62 (Supplement 1):A44.